Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease

Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease

New test as sensitive as next-generation sequencing, and provides five-day specimen stability to support nationwide testing…

Continue Reading
Quest Diagnostics Reputation And At-Home Testing Efforts Catch Investor Attention

Quest Diagnostics Reputation And At-Home Testing Efforts Catch Investor Attention

Quest Diagnostics (NYSE:DGX) has been named to the Fortune 2026 World’s Most Admired Companies list, ranking…

Continue Reading
Quest Diagnostics Is Quietly Becoming Healthcare’s Operating System

Quest Diagnostics Is Quietly Becoming Healthcare’s Operating System

Quest Diagnostics is evolving from a lab test provider into a data-rich diagnostics platform that underpins…

Continue Reading
Quest Diagnostics Reputation And At-Home Testing Efforts Catch Investor Attention

Is Quest Diagnostics (DGX) Using At-Home STI Tests to Redefine Its Consumer Health Strategy?

In November 2025, Visby Medical announced that Quest Diagnostics’ consumer platform, questhealth.com, added the FDA-authorized at-home…

Continue Reading
Quest Diagnostics: Investing In Healthcare’s Future Today (NYSE:DGX)

Quest Diagnostics: Investing In Healthcare’s Future Today (NYSE:DGX)

This article was written by Follow Albert Anthony is the pen name of a Croatian-American business…

Continue Reading
Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration

Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration

With the most comprehensive Epic integration by a laboratory provider, collaboration will streamline and strengthen the…

Continue Reading